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In the preceding paper,  the isolation and some characteristics  of a pneumo- 
coccus manifesting binary capsulation were described (1). This organism, which 
was  shown  to produce  two  capsular  polysaccharides,  was  derived  by trans- 
formation of a non-capsulated  mutant of pneumococcus Type III with deoxy- 
ribonucleates  (DNA)  of pneumococcus Type I. A noteworthy property of the 
SI-III cell is the production by it of approximately normal amounts of Type III 
polysaccharide in contrast to the markedly diminished or absent production of 
this substance by the cell from which it was derived. Two hypotheses to account 
for the restitution of the synthesis of Type III polysaccharide by the cell mani- 
festing binary capsulation are readily apparent. Either that part of the genome 
controlling synthesis of Type III polysaccharide has been restoled to normal in 
the process of cellular transformation to the binary capsular  state or the in- 
creased production of Type III polysaccharide  results  from the  simultaneous 
presence  within the cell of the mutated Type III capsular  genome and  the 
normal Type I  capsular  genome. Distinction between  these  two  hypotheses 
may be made by a study of genetic properties of DNA from the SLIII cell. In 
experiments in which DNA from cells with a binary capsule was applied to non- 
capsulated organisms derived from a strain of pneumococcus Type II, cells of 
the mutant S-m phenotype, SI cells and, rarely, SI-III cells were recovered. No 
organisms of the SIII phenotype have ever been observed in an experiment  of 
this kind. It may be concluded, therefore,  that the augmented production of 
Type III polysaccharide  by the SI-III cell results from the simultaneous pres- 
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ence within the cell of the mutated Type III capsular genome and the normal 
Type I  capsular genome rather  than from reversion to normality of the mu- 
tated Type III capsular locus. From this finding, it follows that there is a  dis- 
crepancy between the genotype and the phenotype of the SI-III cell in so far 
as its Type III capsular component is concerned. 
To elucidate  the mechanism whereby the presence of the  Type I  capsular 
genome brings  about  augmented  synthesis  of Type III polysaccharide when 
resident in the pneumococcal cell together with the mutated Type III capsular 
genome,  a  biochemical reaction  common to  the  synthesis of these  two poly- 
saccharides  was  sought.  All  pneumococci are  believed  to  produce  a  somatic 
polysaccharide, the C polysaccharide, which is apparently a  constituent of the 
bacterial  cell  wall.  This  substance  is  composed  of  mannose,  galactose,  and 
acetylglucosamine (2). The constituents of Type I  capsular polysaccharide are 
known only in part and consist of galacturonic acid, an acetylhexosamine and 
an uncharacterized moiety (3, 4). Type III capsular polysaccharide is made up 
of glucuronic acid and glucose (5). The possibility that some relationship might 
exist between the biosyntheses of the uronic acid components of the two cap- 
sular  polysaccharides  was  suggested  by  these  facts  and,  consequently,  an 
investigation  of  the  uronic  acid  metabolism  of  a  variety  of  pneumococcal 
strains was undertaken. 
The importance of uridine nucleofides to the metabolism of uronic acids in 
mammalian tissues has been shown by a number of investigators (6). Study of 
several strains of pneumococcus has demonstrated also the probable importance 
of such nucleotides to the carbohydrate metabolism of these organisms (7,  8). 
From an analysis of the content and type of uridine nucleotides of a  number 
of pneumococcal variants and from an examination of the enzymes concerned 
with  their formation, it has been possible to  establish the probable basis for 
the  augmented  synthesis  of  Type  III polysaccharide  in  cells  of  the  SI-III 
phenotype and  to make several observations pertaining  to the structure  and 
behavior of the capsular genome of pneumococcus. 
Materials and Methods 
Nomenclature of Pneumococcal Variants.--Because  of the lack of correspondence  of capsular 
genotype and phenotype both in non-capsulated variants of pneumococcus and in variants 
with a binary capsule, it is necessary to introduce separate designations for each. The terms 
descriptive of phenotype with one addendum will be those set forth in the preceding paper. 
When two capsular genomes coexist within the cell and only one capsular polysaccharide is 
expressed, the presence of the cryptic genome will be included in parentheses. For example, 
phenotype SIII(I) contains mutated genomes  of both Type I and Type III but expresses  only 
Type III polysaccharide. To describe the capsular genotype, the following conventions will 
be used. Each enzyme to be considered will be designated by a capital letter when present in 
its normal state.  Mutations characterized by reduced or by absent enzymatic activity will 
be described by the corresponding letter in lower case. When experimental conditions do not 
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will be enclosed in parentheses. Subscripts in Roman numerals will be employed to indicate the 
capsular type designation of the strain from which the DNA determining the enzyme was ob- 
tained. Superscripts in Arabic numerals will be used to indicate variants with different muta- 
tions in the same enzymatic step or cistron (9). The entire capsular genome of a given capsular 
type will be delineated by vertical bars. When two capsular genomes coexist within the same 
cell,  their characterizations will be separated by a dot. 
The enzymes to which reference will be made are designated as follows: 
Uridine pyrophosphogalactose-4-epimerase:  A 
Uridine pyrophosphoglucose dehydrogenase:  B 
Uridine pyrophosphogalaeturonic acid-4-epimerase:  C 
The undesignated residue of the capsular genome including the polymerizing system:  P 
An example of the phenotypic and genotypic description of a pneumococcal strain follows. 
S--h has genotype [Bff~(PI)[. It is a  noncapsulated variant of  pneumococcus Type I  which 
fails to produce capsular polysaccharide because of its inability to convert the uridine nucleo- 
tide of glucuronic acid to that of galacturonie acid. It may be seen that a genetically distinct 
strain  with a  mutation  affecting the  same  biochemical  function,  [BIc~(PI)],  would  give 
rise to the same phenotype; i.e., S--Is. 
For convenience, uridine nucleotides will be designated by the following abbreviations. 
Uridine pyrophosphoglucose:  UPPG 
Uridine pyrophosphogalactose:  UPPGal 
Uridine pyrophosphoglucuronic acid:  UPPGA 
Uridine pyrophosphogalacturonic acid:  UPPGalA 
Strains of Pneumococcus.--In  addition to the strains described in the preceding report, 
the following organisms were employed. 
S-I  phenotypes--S-h:  a non-capsulated mutant derived from Strain I41S. 
S-t~:  a non-capsulated mutant derived from Strain ID. 
S--Is:  a non-capsulated mutant derived from Strain SVL 
SIX,  SXIV,  SXVIII,  SXXII,  SXXV,  and  SXXXIII: capsulated  strains of Types  IX, 
XIV, XVIII, XXII, XXV, and XXXIII isolated from patients with pneumonia. 
Preparation  of DNA  and  Technique  of  Transformation  Reactions.--The methods  were 
those described by MacLeod and Krauss (10). 
Extraction and Identification of Uridine Nudeotides  of Pneumoeoccus.--The  organisms were 
grown in 4 liter cultures of Difco brain-heart infusion broth containing 0.1 per cent neopep- 
tone to which 1 per cent glucose had  been added  after incubation overnight. Lactic acid 
formed was neutralized with 3  ~; NaOH and the cells were harvested at  the beginning of 
the stationary phase of the growth curve by centrifugation. Nucleotides were released from 
formalinized cells by boiling an aqueous suspension followed by freezing and thawing. The 
filtered  lysate was  passed  through a  Dowex-1  CI'  column  to  which  the nncleotides were 
absorbed. Fractional elution was carried out with dilute HCI and increasing concentrations 
of NaC1.  The eluates were adsorbed with norite, eluted with ethanol, and chromatographed 
on  paper.  Glucuronic and  gaiacturonic acid  were  distinguished by  ionophoresis on  paper 
of their borate complexes.  Details of the methods employed have been described elsewhere 
(7, 8). 
Isdation  of Enzymes  Concerned with  the Metabolism  of  Uridine  Nudeotides.--Bacteria 
were grown in 500 cc. cultures of the medium described above and harvested in the logarith- 
mic phase of growth. The cells were disrupted with ballotini in a Mickle disintegrator at 4°C. 
and  the material released was precipitated with 3  ~  (NH,)2SO4.  The precipitate was ad- 
sorbed and fractionally eluted from celite to obtain the active materials studied. The sub- 
strates employed were UPPG,  CX4-1abelled UPPG and UPPGA. End products of the  reac- 
tions  were  identified  by  chromatographic  and  by  ionophoretic  methods.  The  techniques 
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EXPERIMENTAL 
Genetic and Biochemical Properties of Capsulated and Non-Capsulated Variants 
o/ Pneumococcus Type  IlL--Examination  of  the  nucleotides  of  capsulated 
strains of pneumococcus Type III shows both UPPG and UPPGA to be present 
in  significant  amounts and  an  active  dehydrogenase  capable  of converting 
UPPG to UPPGA can be isolated from such organisms. Examination of four 
non-capsulated mutants of pneumococcus Type III reveals the near or complete 
absence of UPPGA from their cells, and enzymatic activity resulting  in oxi- 
dation of UPPG to UPPGA is of a very low order when compared with that of 
fully capsulated Type III cells. None of these mutants is virulent in mice. An 
additional  attribute  of  the  four  non-capsulated  variants  of  pneumococcus 
Type III is that each can be transformed to the SI-III phenotype with DNA 
from pneumococcus Type I. This observation indicates that each strain retains 
its genetic  determinants for the polymerization  of Type III polysaccharide 
and is able to carry out this activity when the constituents necessary for it can 
be provided by the cell. There is no evidence of any kind to suggest  that a 
wild Type I  pneumococcus  is endowed with the latent ability to synthesize 
Type III capsular material. 
The observations  described may be interpreted to indicate that each of the 
four non-capsulated  variants of pneumococcus Type III has a  mutation in- 
volving the formation of UPPG dehydrogenase by the cell. That loss of enzy- 
matic activity is not the result of a suppressor  mutation is evident from the 
work of Taylor (12) who pointed out that capsulated Type III organisms were 
never recovered when DNA from non-capsulated mutant Type III cells was 
applied  to non-capsulated  cells derived  from an heterologous  capsular  type. 
Her observations have been confirmed repeatedly in these experiments. 
Although the four non-capsulated mutants are phenotypically similar, they 
are,  as  shown  first  by  Ephrussi-Taylor  (13), genotypically distinct.  DNA 
from each strain will transform cells of any of the three other strains to the 
normal SIII phenotype and genotype. The relationships among the four strains 
resemble,  therefore,  those  of  non-identical  alleles  with  the  genetic  lesions 
occurring  at different  sites  in a  single cistron.  The data are summarized in 
Table I. 
Genetic and Biochemical Properties of Capsulated and Non-Capsulated Variants 
o/Pneumococcus Type/.--In Table II are set forth the data obtained from the 
analysis of pneumococcus Type I  and of several non-capsulated  variants de- 
rived from it. It may be seen that capsulated Type I cells produce a nucleotide 
not  present  in  capsulated Type  III  cells, namely UPPGalA.  As  reported 
previously  (14), this nucleotide  is derived from the epimerization  of UPPGA 
rather  than from  the  oxidation of  uridine pyrophosphogalactose.  The  bio- 
chemical pathways concerned with the formation of uronic acids in pneumo- 
coccus are summarized in Fig. 1. Because two enzymatic steps are involved in AUSTRIAN,  BERNHEIMER,  SMITH~ AND  MILLS  589 
the derivation of UPPGalA from UPPG, it was  not unexpected that mutants 
affecting each of these enzymatic capacities would be found. Like the S-m 
variants described earlier, strain S--~, has a mutation affecting the formation 
TABLE  I 
Biochemical Properties  and  Genotypic Description  of Normal and  Mutated  Strains  of 
Pneumococcus Type IH 
Phenotype 
SIII 
S-  IIh 
S-IH2 
S--III3 
S-HI4 
Nucleotide content 
UPPG  UPPGA 
+  + 
+ 
+ 
+ 
+ 
Content of 
UPPG 
dehydrogenase 
+ 
4_ 
4- 
_4_ 
4- 
Presence or 
absence of 
polymerizing 
system 
+ 
+ 
+ 
+ 
+ 
Genotype 
[BIIIPIrII 
[b~xiPIzzl 
Ib~,Pml 
Ib~iIPIxl[ 
Ib~iiPIIIl 
+, present; --, absent; 4-, detectable but reduced markedly. 
TABLE II 
Biochemical Properties and  Genotypic Description of Normal  and  Mutated Strains  of 
Pneumococcus Type [ 
Phenotype 
sI 
S-- I1 
S- I2 
S~ I3 
Nucleotide  content 
UPPG 
+ 
+ 
+ 
+ 
UP~GA  I  UPP-  GalA 
+ 
+ 
n 
+ 
Enzyme content 
UPPG 
dehydro- 
genase 
+ 
+ 
-4- 
+ 
Uronic 
acid 
epimerase 
_ 
q- 
+ 
Presence or 
absence of  polymerizing  Genotype 
system 
q"  [B,CIPr[ 
IS,c~(et)[ 
IblC,(P,)l 
IB,/,(P,)I 
+, present;  --, absent;  q-, detectable but reduced markedly. 
of UPPG dehydrogenase.  It  is  noteworthy, however,  that  an  active uronic 
acid epimerase is  found in  the  cells of this strain  despite  the absence of its 
substrate,  UPPGA.  Strains  S--rl  and  S--rs  have  mutations  affecting  the 
formation of UPPGalA from UPPGA. UPPG dehydrogenase activity is demon- 
strable in both strains and UPPGA can be isolated from the cells of each. Like 590  PRODUCTION  OF  CAPSULAR  POLYSACCHARIDES.  H 
non-capsulated variants  of pneumococcus Type III,  those of capsular  Type 
I  also lack virulence in mice. 
DNA from strain S- is will transform cells of strain S-- it to capsular Type 
I and the two strains appear to represent, as do the S- m  variants, non-identi- 
cal mutations involving a  single cistron. Transformation of S--i~  to capsular 
Type I  can be effected also with DNA from strain S-i~ and the relationships 
are reciprocal; i.e., cells of S-x, can be transformed to Type I  with DNA of 
the  aforementioned  strain.  These  reactions  are  characterized,  however,  by 
recombination  of  two  enzymatic functions  and  are  analogous  to  a  genetic 
recombination involving two cistrons. 
No system of recombination is currently available to test for the intactness 
of  the  polymerizing mechanism  in  the  non-capsulated  variants  of pneumo- 
Phosphoglucosyl 
uridyl 
transferase 
G-I-P  . 
UTP 
UPPG 
dehydrogenase 
UPPG 
DPN 
I 
Epimerase 
DPN 
UPPGal 
I 
C  Polysaccharide  (?) 
FIG.  1. Pathways  of uronic acid metabolism in pneumococcus. 
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coccus Type I  and its status in the strains studied is uncertain. The ability of 
strain S-i2  to mutate back to the fully capsulated state in certain selective 
environments suggests that the polymerizing system in this cell is intact, for 
such reversion to the capsulated state would doubtless be observed infrequently 
were two mutations required to bring it about. 
Some  Properties  of the Capsular  Genome Manifested  by  Transformation  of 
Non-Capsulated  Pneumococci to the Capsulated State.--The  data presented so 
far indicate that the capsular genome of pneumococcus is complex and controls, 
through the agency of independently variable factors, the execution of a number 
of biochemical reactions. It is apparent also that when such reactions involve 
a sequential pathway, a mutation anywhere along that pathway may result in 
loss  of  capsulation  without  affecting  unrelated  or  antecedent  biosynthetic 
reactions. Loss of capsulation, therefore, is not accompanied necessarily by loss 
or alteration of the entire capsular genome. This assertion is borne out by the 
fact that a  number of non-capsulated pneumococci derived from a variety of 
capsular types have been found which still produce UPPGA, a  non-essential AUSTRIAN~ BERNHEIMER,  SMITH~ AND  MILLS  591 
constitutent for viability of the pneumococcal cell. It is noteworthy that such 
non-capsulated strains have been derived only from capsulated organisms which 
include  an uronic acid as a  constituent of their capsular  polysaccharide.  Re- 
tention of the ability to produce UPPG dehydrogenase,  uronic acid epimerase 
and UPPGA  can be  used,  therefore,  as  markers of the capsular  genome in 
non-capsulated  pneumococci,  and  the  behavior  of  these  markers  in  trans- 
formation reactions can be studied. Previous investigations  have demonstrated 
the absence of uronic acid from the capsular  polysacharides  of pneumococcus 
Types XIV and XVIII (15, 16). Examination of the ceils of these  capsular 
types revealed,  in  addition,  the absence of UPPGA and of UPPG dehydro- 
genase,  findings  consistent with the earlier  observations.  Accordingly,  DNA 
was prepared from strains of pneumococcus Types XIV and XVIII and non- 
capsulated pneumococci  producing  UPPGA  were  transformed to  these  two 
capsular types. Analysis of the transformed cells (Table III) shows loss of the 
TABLE III 
Biochemical Properties of Non-Capsulated Variants of Pneumococeus Types I  and II before 
and after Transformation to Capsular Types XIV and XVIII 
Non-capsulated  UPPGA  UPPG  Transformed  UPPGA  UPPG 
Phenotype  dehydrogenas¢  phenotype  dehydrogenase 
S- I~  +  + 
S--If  +  + 
XIV 
XVIII 
XIV 
XVIII 
D 
ability to  synthesize  UPPGA manifested by the non-capsulated  cell before 
transformation. In an analogous fashion loss of the ability to epimerize uronic 
acid by the non-uronic  acid producing  strain S-x~ following transformation 
to Type III can be demonstrated. The results  of these  experiments  suggest 
that, in a given pneumococcal cell, a specific region of its genetic structure is 
occupied by the capsular genome and that the capsular genome of one capsular 
type present in preparations of DNA replaces in the transformation reaction, 
in a  manner analogous  to  "crossing  over," the normal or mutated capsular 
genome present in the cell. This type of genetic  exchange has been  demon- 
strated  previously  in  transformations affecting  mode  of  cellular  separation 
after division  (17) and in the presumed  direct transformation of capsulated 
pneumococci to an heterologous capsular type (18). 
Trar~formation of Pneumococci of the S--m  Phenotype with DNA from Type 
I  Pneumococcus.--Transformation  of  S--I,,  pneumococci  with  DNA  from 
pneumococcus  Type I  results  in the appearance  of two transformed pheno- 
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Each of the S--m variants listed in Table I  can be transformed to the SI 
phenotype. DNA from such transformed Type I cells, like that from wild Type 
I cells, will transform the same S- m variants to the SI and SI-III phenotypes. 
It is  noteworthy, however,  that, after any of the  S-m  variants has been 
transformed to the Type I phenotype, DNA from it will no longer react with 
genetically heterologons S-m  variants to give rise to Type III pneumococci. 
The finding indicates  that the S--m cell transformed to capsular Type I has 
lost its mutated Type III capsular  genome and has acquired in its stead, the 
normal Type I  capsular  genome. In so doing, it has acquired  also the ability 
to carry out three biochemical functions: the conversion of UPPG to UPPGA, 
the conversion  of UPPGA  to UPPGalA and the polymerization of Type I 
capsular polysaccharide. 
Transformation to the binary capsular SI-III phenotype occurs also following 
exposure of S--m cells to DNA from Type I  pneumococci. The phenotype 
and genotype of an SI-III strain are shown in Table IV. Evidence supporting 
this structure for the genotype of the SI-III strain is derived from study of the 
phenotypes and genotypes obtained following transformation of a non-capsu- 
lated mutant of pneumococcus Type II with DNA from SI-III cells. Pneumo- 
cocci of three different phenotypes are recovered:  S--m, SI, and SI-III, the 
last being an infrequent finding. It is noteworthy that no SIII cells are observed 
and all the experimental data indicate that recombination  between subunits of 
the SI and SIII capsular genomes does not take place; i.e.,  wild type B1 does 
not correct the alteration bm in the mutated Type III strain by recombining 
to give the hypothetical genome I BiPml  . Each capsular genome in the wild 
type or mutated state behaves as a tightly linked unit composed of recognizable 
subunits controlling a variety of biochemical functions. 
It is apparent also from examination of SI-III cells that this variant pro- 
duces an approximately normal amount of Type III capsular  polysaccharide 
despite the absence from it of the normal Type III capsular genome. In addition, 
the amount of Type I capsular material, as judged from the quellung reaction, 
is distinctly less than that produced  by most unitypic Type I  strains. From 
an analysis of the capsular genome of the SI-III cell, it may be concluded that 
the Type I  capsular  genome functions as an augmenter of Type III capsular 
polysaceharide  synthesis by providing  UPPGA and conversely, the mutated 
Type III capsular  genome suppresses partially the synthesis of Type I  poly- 
saccharide  by competing for an intermediary metabolite essential  for its for- 
mation. 
Further support for these interpretations may be had from an examination 
of the behavior of S--m cells exposed in the transforming system to DNA 
from different non-capsulated strains derived from capsular Type I. From the 
data in Table IV it is apparent that DNA of non-capsulated variants of pneu- 
mococcus Type I  which  lack uronic  acid epimerase  but continue to oxidize AUSTRIAN, BERNHEIMER~ SM.ITH~ AND MILLS  593 
UPPG  to  UPPGA are  capable of transforming S-m  cells  with a  resultant 
increase  in  the formation of Type  III polysaccharide. Although these  cells 
produce no Type I polysaccharide because of their inability to form UPPGalA 
from UPPGA and are phenotypically indistinguishable from strains of SIII, 
genotypically they are related closely to strains of the SI-III phenotype and 
are designated SIII(I) because the mutated Type I capsular genome is carried 
TABLE IV 
Phenotypic  and Genotypic Description  of Pneumococci before and after Transformation 
Recevtor cell 
Phenotype  Genotype 
4 
S--III,  {bnxPIIII 
S-xI  Bn(Prr)[ 
Source of DNA  Transformed cell 
Phenotype  Genotype  Phenotype  Genotype 
S-- III~  [b~IIPIxI[  SIII  ]BIIIPIIII 
SI  IBICIPI]  SI  IBICIPI[ 
SI-III  IbllIPlII["  IBxCxPr[ 
S- x~  IBxe~(gx)  I  Sill(l)  Ib~xxexxxl"  IBx*~(Px)  [ 
S-x~  Ib~Ci(Pi)[  S-  Not examined 
SI-III  [blllPIII[" [BICIPI[  S-- III4  [b~rlPIII[ 
sI  IBxc~Pxl 
SI-III  [b~iiPIIIl" [BICIPI[ 
S-ni~  '[b~iiPiii[ 
S- i~  Ib~CI(PI)[ 
s-i,  IB~(Px)I 
4  1  SlII(I)  [bmPxul" IBIcI(PI) I  Sill  [BmPmt 
Sill(I)  tb~uPiii["  IBicX~(Pi)  l  SI  IBICIPII 
S--It  lb~tCI(PI)l  SI  [BICIPI[ 
S-- I*  IBIc](PI) [  SI  [BICIPI] 
cryptically. DNA  from an  SIII(I)  strain  applied  to  an heterologous S--m 
strain will transform it to the Type III phenotype and genotype. The same prep- 
aration of DNA will transform an heterologous S-I strain to the Type I pheno- 
type and genotype. The results are in accord with those described by Hotchkiss 
(19)  concerning the  "repair" of alterations in the maltase locus in pneumo- 
coccus.  "Small" alterations are  restored to  the normal state  through trans- 
formation more  readily  than  are  "large" ones. In capsular transformations, 
restoration to wild type by intratype transformation occurs in most instances 594  PRODUCTION  OP  CAPSULAR  POLYSACCHARIDES.  II 
at a higher frequency than does transformation to heterologous or to  binary 
capsular types. 
Non-capsulated  strains of pneumococcus Type I which, in contradistinction 
to those employed in the previous experiments, have lost their ability to syn- 
thesize UPPGA possess DNA which is incapable  of leading to augmentation 
of Type III polysaccharide  synthesis on the part of the S-m  cell. Because 
neither the cell to be transformed nor that serving  as a source of DNA can 
produce UPPGA, the result of such experiments is the anticipated one. 
In transformation reactions  involving  cells of S--xlI phenotypes and  the 
non-capsulated variant of pneumococcus type I, S- I1, which produces UPPGA, 
cells of each strain may function as the donor of or as the recipient of the DNA 
of  the heterologous  capsular  genome. Although S-m  cells may accept the 
capsular  genome of wild or of mutated variants of pneumococcus Type I, no 
strains have been  isolated  in which  a  normal or mutated Type I  capsular 
genome coexists in the cell with a normal Type III capsular genome. Whether 
or not the latter relationships  can be established  cannot be ascertained  from 
available  data; but,  if they are  possible  ones,  their occurrence  must be  in- 
frequent. 
The Ability of DNA of Pneumococci, the Capsular Polysaccharides  of Which 
Contain Uronic Acid, to Give Rise to Binary Capsulation.--It has been recognized 
for a number of years that uronic acids are constituents of polysaccharides of 
pneumococci of several  capsular  types (20, 21). If the interpretations of the 
phenomenon of binary capsulation  set forth above are correct, it is reasonable 
to anticipate that DNA from capsulated pneumococci other than that from 
pneumococcus Type I  might give rise to variants manifesting binary capsu- 
lation. In Table V are recorded the results of transforming four genotypicaily 
distinct variants of the S-- m phenotype with DNA from a variety of capsulated 
pneumococci each of which includes an uronic acid in its capsular polysaccha- 
ride.  It may be seen  that cells of three additional phenotypes with binary 
capsules have been isolated: SIII-IX, SIII-XXV, and SIII-XXXIII. Although 
augmentation of the synthesis of Type III polysaccharide is clearly manifested 
by cells of each of these phenotypes, in none is it as pronounced as by cells of 
the SI-III phenotype. Colonies of cells of these phenotypes, therefore, may be 
difficult to distinguish  from those of singly capsulated strains.  Noteworthy is 
the fact that, to date, no one of the S-m  strains has been found capable of 
being transformed to all the recognized phenotypes manifesting binary capsu- 
lation and also that DNA from some strains of capsulated pneumococci pro- 
ducing uronic acid; e.g., Types II, VIII, XXII, have failed to give rise to the 
phenomenon of binary capsulation.  The explanation  of these variations in the 
behavior of different cell lines is not apparent at the present.  The occurrence 
of phenotypes with binary capsules other than SI-III, however, is in accord 
with the stated hypothesis concerning the mechanism of augmented synthesis 
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DNA from cells of each of the phenotypes manifesting binary capsulation 
has been tested in transformation reactions  with appropriate receptor  strains. 
In each instance, augmentation of the synthesis of Type III capsular poly- 
saccharide appears  to result from the simultaneous  presence within the cell of 
the mutated Type III capsular genome and the normal capsular genome of the 
second  capsular  type.  In no instance has  there been  evidence  of alteration 
toward normal of the mutated Type III capsular genome, cells of each pheno- 
type with a binary capsule seeming to be constructed genetically in a fashion 
analogous to those of the SI-III phenotype. 
Utilization  of Binary Capsulation as an  Indicator of the Presence of Uronic 
Acid in Capsular Polysaccharide.--If  DNA from a  capsulated pneumococcus 
TABLE  V 
Phenotypes Recovered  Following Transformation of Non-Capsulated Mutants of Pneumococeus 
Type IH with DNA from Capsulated Pneumoeocci Producing UPPGA 
Strain  Source of DNA 
trans- 
formed 
S-  III1 
S-- III2 
S- 1112 
S-  III4 
I 
I 
I-III 
I 
l-Ill 
I 
l-Ill 
I 
I-III 
II 
II 
II 
II 
II 
III  V 
III  -- 
III  -- 
III  -- 
III  V 
III-V 
VIII 
VIII 
VIII 
VIII 
VIII 
I  IX 
IX 
IX 
III-IX 
IX 
III-IX 
IX 
xxII 
XXII 
XXII 
XXII 
XXII 
XXV  XXXIII 
III-XXV  XXXIII  III-XXXIII 
XXV  XXXHI 
III-XXXIII 
XXV  XXXIII 
III-XXKIII 
XXV  XXXIII 
III-XXV 
gives rise to a phenotype with a binary capsule when allowed to react with cells 
of an S-m  strain in the transforming system, its cells should  be capable  of 
synthesizing UPPGA and its capsular polysaccharide should contain an uronic 
acid. Transformation of strain S- m, with DNA from pneumococcus Type V 
has led to the isolation of cells of the SIII-V phenotype. Although the composi- 
tion of Type V polysaccharide was unknown at the time the SIII-V phenotype 
was isolated,  it was predicted that UPPG dehydrogenase  and UPPGA would 
be present in its cells and an uronic acid would be a constituent of its capsular 
polysaccharide.  Analysis  of Type V cells and  polysaccharide  has  confirmed 
fully these predictions  (22). 
DISCUSSION 
Investigation of certain uridine  nucleotides  and of the enzymes  concerned 
with  their formation in pneumococcus  has  led  to  a  number  of findings  of 596  PRODUCTION  OF  CAPSULAR  POLYSACCHARIDES.  H 
interest. The relation of the ability to synthesize uronic acids to maintenance 
of the capsulated state and concomitantly of virulence in certain pneumococcal 
types is clearly evident. Failure to synthesize UPPGA results in loss of capsula- 
tion by pneumococci of Types I  and III and the inability to convert UPPGA 
to UPPGalA causes a  similar  effect in pneumococcus Type I.  It is  obvious 
that  mutations  affecting  metabolic  functions  other  than  those  related  to 
uronic  acids may cause loss  of capsulation,  for capsulated strains  of Types 
XIV and  XVIII,  which produce no  uronic  acids,  may mutate  to  the  non- 
capsulated state.  Even types of pneumococci which include glucuronic  acid 
as  an  important  constituent  of  their  capsular  polysaccharide  may  mutate 
to  the non-capsulated  state  without loss  of the ability to form UPPGA.  A 
non-capsulated  strain  of  pneumococcus  Type  II  and  two  non-capsulated 
variants  of pneumococcus Type VIII  have  each  been  found  to  retain  the 
ability to synthesize the uridine nucleotide of glucuronic  acid while failing  to 
produce capsular polysaccharide.  It is  evident  also  from  these  observations 
that loss of capsulation by pneumococcus does not necessarily entail deletion 
of the capsular genome  but may result from an alteration  affecting  any one 
of the several biochemical  activities determined by it. 
From a  study of non-capsulated variants  of pneumococcus Type III,  the 
frequency with which mutation  alters  the activity of UPPG dehydrogenase 
in such strains is readily apparent. Of eight phenotypically similar, genotypically 
distinct S- 1ix phenotypes, all have been found to have mutations affecting this 
biochemical  activity.  Most  of  these  strains  manifest  slight  but  detectable 
UPPG dehydrogenase activity and behave as  "leaky" mutants  described in 
other bacterial species. They retain intact, however, the metabolic capability 
of polymerizing Type III polysaccharide. This finding  does not preclude the 
occurrence  in  other  non-capsulated  variants  of pneumococcus Type  III  of 
mutations affecting the polymerizing  system which may result in loss of capsu- 
lation. On the other hand, mutations preventing the formation of UPPG would 
probably be lethal mutations.  Strains of pneumococcns grown in the absence 
of galactose must form this constituent of their C or cell wall polysaccharide 
by the epimerization of UPPG to UPPGal. Although mutations in the struc- 
ture of C polysaccharide have been shown by McCarty (23) to be consistent 
with  cellular  viability  in  Group  A  beta  hemolytic  streptococci,  mutations 
of this character have not been described to date m  pneumococcns.  It is of 
interest that the mutations affecting the C polysaccharide of Group A strepto- 
coccus alter its content of acetylglucosamine, a  constituent of pneumococcal 
C polysaccharide. 
Through  the  investigation  of  capsulated  and  non-capsulated  variants  of 
pneumococcus Type I, the biochemical pathway for the synthesis of galactu- 
tonic  acid  has  been  elucidated.  Although  initially  it  appeared  likely  that 
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sumed required presence of the latter for the formation of C polysaccharide, 
such did not prove to be the case.  UPPGA was found first in non-capsulated 
and  later  in  capsulated  variants  of pneumococcns  Type  I  and  an  enzyme 
capable of converting UPPGA to UPPGalA was demonstrable in the latter 
(14).  This pathway for the synthesis of galacturonic acid appears to be wide- 
spread in nature, for it has been reported to be present in mung bean seedlings 
and several other plants (24).  It is of probable importance in the synthesis of 
pectins, which are polygalacturonic acids, as well as in the synthesis of Type 
I pneumococcal capsular polysaccharide. 
Observations  on the transformation of non-capsulated pneumococci  to  an 
heterologous capsular type raise several questions of interest. From the experi- 
mental data, it seems likely that in a  given pneumococcal cell,  the capsular 
genome is relegated to a specific region of the total genome. If this is the case, 
it  appears  that,  when  transformation  occurs  with  acquisition  of  new  bio- 
synthetic  capabilities  and  loss  of  ones  possessed  previously by  the  cell,  a 
reaction analogous to "crossing over" has taken place between the two capsu- 
lar genomes, the one of the cell and that present in the DNA inducing trans- 
formation. Such an event presupposes antecedent pairing of the two capsular 
genomes. In view of the rather marked dissimilarities of biochemical function 
requisite for the synthesis of different pneumococcal capsular polysaccharides, 
the question arises whether or not special determinant groupings, not related 
necessarily to the specific processes of capsular synthesis, may be responsible 
for such pairing. Such determinants might be DNA or conceivably some other 
material such as protein. It is of interest that although non-capsnlated pneu- 
mococci derived from other  than Types  I  and  III have  been  transformed 
directly  to  the binary  capsular  SI-III  phenotype  with  DNA  from  cells 
of this binary capsular type, such a  transformation is an uncommon  event, 
and  segregation of  the  two  capsular genomes is  observed more  commonly. 
It is noteworthy, however,  that some relationship appears  to exist  between 
the  two capsular genomes of the cell with a  binary capsule,  for only DNA 
from  such  cells  has  been  observed  to  transform  unrelated  non-capsulated 
variants  to  the  binary capsular  state.  Mixtures  of  two  DNA  preparations 
each beating one of the two capsular genomes have failed to yield comparable 
results.  "Linkage" between the mutated Type III genome and  the  normal 
Type I  genome in cells  of the SI-III phenotype, however, is evidently of a 
low order if, indeed, it truly exists. 
Examination of the capsular genome of Type I and of Type III pneumococci 
shows each to control several biochemical activities concerned with the syn- 
thesis of the capsule. In capsular transformation, the genetic factors controlling 
these several activities appear to reside in a single particle of DNA and to be 
transferred in intertype transformations as a  unit. In the case of the Type I 
capsular genome, which cogtrols a  minimum of three biochemical activities, 598  PRODUCTION  OF  CAPSULAR  POLYSACCHARIDES.  II 
the frequency of intertype transformation to capsular Type I effected by DNA 
from Type I pneumococci is too high to be accounted for on any other basis. 
In  addition,  examination of  the  capsular  genome  of  variants  manifesting 
binary capsulation  fails to give any evidence that a  subunit of the Type I 
capsular  genome can recombine with the mutated Type III capsular  genome 
resident within the same cell, for normal Type III strains are not recovered 
in such reactions. 
Intratype transformations of two kinds may be discerned from the study of 
genetic interactions between non-capsulated  variants of Type I  and between 
non-capsulated strains of Type III. The capsular  genomes of phenotypically 
similar,  genotypically distinct variants of pneumococcus Type I  with muta- 
tions affecting the activity of uronic acid epimerase may undergo recombina- 
tion in transformation reactions  with restoration of that enzymatic function 
and of capsular synthesis to normal. In analogous fashion, the capsular genomes 
of mutant Type III strains with mutations affecting  UPPG dehydrogenase 
may interact.  In  each  instance,  these intratype reactions  are  analogous  to 
those described by Benzer  (9)  as affecting a single cistron.  A second type of 
intratype reaction may occur between non-capsulated mutants of pneumococcus 
Type I  distinguishable  by their different  enzymatic alterations. In reactions 
of this kind, interaction between  the capsular  genomes of the two variants, 
one with a mutation affecting UPPG dehydrogenase  and the other with one 
affecting uronic acid epimerase, leads to restoration of the synthesis of Type 
I polysaccharide. In transformations of this kind, two "cistrons" are involved. 
Because of the absence of suitable  selective techniques, information is lacking 
concerning  segregation  of the genetic  subunits of a  given  capsular  genome. 
The data relating to  binary capsulation derived from the strains  described 
herein indicate that, if such divisions of the capsular  genome do occur,  they 
do  not  lead  to  the  formation of  structures  which  participate  in  intertype 
reactions. 
Because of the nature of the transformation reaction, it has not been possible 
to determine with assurance whether or not recombination between the genome 
of the cell and that taken up from its environment has occurred as a result of 
physical  exchange of DNA or of copy choice. A third mechanism  of genetic 
variation is suggested by experiments  of MacLeod and Krauss (25) wherein 
non-capsulated  mutants  of  pneumococcus  Type  VIII  are  transformed  to 
capsular  Type VIII by DNA from organisms of heterologous  capsular type. 
The results  are compatible  with the view that introduction into the cell of 
certain heterologous  particles  of DNA may alter the stability or mutability 
of a  given locus. Such an hypothetical event might be considered  analogous 
to the phenomena of conversion described by Lindegren (26) and by Mitchell 
(27)  and of paramutation reported by Brink  (28). In view of the apparent 
failure  of the units controlling  the synthesis of UPPG dehydrogenase  to re- 
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III,  there  arises  the question of whether  or not recombination  takes  place 
in  intratype  transformations  involving  the  cistron  controlling  this  enzyme. 
At present,  the possible influence  of a  capsular genome  taken up by the cell 
upon that already resident within the genome of that cell cannot be excluded. 
Such  an  event would provide a  plausible,  though  unproved  explanation  of 
the several phenomena described. 
Binary capsulation in pneumococcus provides an example  of a  competitive 
biochemical reaction with one metabolic pathway vying for an intermediary 
product of another. The intracellular relationships are such that in the SI-III 
phenotype,  the mutated  Type III  capsular  genome  acts  as a  suppressor of 
the end  product of the Type I  capsular genome  and  conversely,  the latter 
functions to augment expression  of the phenotype controlled by the former. 
Here  genetic  suppression  and  augmentation  can  be  defined  in  biochemical 
terms.  These findings  may be somewhat analogous to those resulting in the 
formation of Sab phenotypes of H. influenzae when Rb cells are transformed 
with  DNA  from  Sa  strains  of the same  species  (29). The  biochemical  basis 
for the latter reaction is at present undefined.  Another interesting feature of 
the pneumococcal phenotype manifesting binary capsulation is the fact that 
it  permits  recognition  of  the  persistence within the non-capsulated variants 
of pneumococcus Type III of the biochemical  system requisite for the poly- 
merization of Type III polysaccharide. This capacity of the mutant Type III 
strains  cannot  be identified  at  the  present  time  by biochemical  techniques 
but can be demonstrated through genetic interactions.  Analogous  recombina- 
tions  permitting  recognition  of  the  capsular  polymerizing  systems  of other 
non-capsulated pneumococci have not yet come to light. 
Definition  of the  biochemical  relationships  existent  within  the  SI-III  cell 
have permitted predictions concerning  genetic interactions  which might  lead 
to the formation of other binary capsular phenotypes; and, in three instances, 
such predictions have been realized  with the formation of additional types of 
cells manifesting binary capsulation: SIII-IX, SIII-XXV, and SIII-XXXIII. 
Why  DNA  from  other  capsulated  strains  of  pneumococci  which  produce 
uronic acids fails to give rise to the phenomenon of binary capsulation is not 
understood at the present time. 
In a fashion analogous to the use of serologic cross-reactions  to obtain data 
indicative  of the structure  of polysaccharides  (30),  transformation  reactions 
giving rise to binary capsulation may be employed. Although the structure of 
Type V pneumococcal polysaccharide was unknown, DNA from Type V strains 
was found to give rise to cells of the SIII-V phenotype in transformation reac- 
tions with an S-- in variant. On the basis of this finding, it was predicted that 
UPPG dehydrogenase and UPPGA would be present in the cells of Type V 
pneumococci and that Type V capsular polysaccharide would have an uronic 
acid as one of its components. These predictions have been confirmed  (22). 
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of facts related  to  the genetic  and  biochemical properties  of this  organism. 
Further study of the phenomenon should provide additional  data  of general 
biological interest. 
S~RY 
Study of the capsular genome of pneumococcus has shown that it controls a 
multiplicity  of  biochemical  reactions  essential  to  the  synthesis  of  capsular 
polysaccharide. 
Mutation affecting  any one of several biochemical reactions concerned with 
capsular synthesis may result in loss of capsulafion without alteration of other 
biochemical functions similarly concerned. 
Mutations affecting the synthesis of uronic acids are an important cause of 
loss of capsulation and of virulence by strains  of pneumococcus Type I  and 
Type III. 
The capsular genome appears to have a specific location in the total genome 
of  the  cell,  this  locus being  occupied by the  capsular  genome  of  whatever 
capsular type is expressed by the cell. 
Transformation of capsulated or of non-capsulated pneumococci to heterol- 
ogous  capsular type results probably from a genetic exchange followed by the 
development of a new biosynthetic pathway in the transformed cell. The new 
capsular genome is transferred to the transformed cell as a  single particle of 
DNA. 
Binary capsulation results from the simultaneous presence within the pneu- 
mococcal cell of two capsular genomes, one mutated, the other normal. Interac- 
tion between the biochemical pathways controlled by the two capsular genomes 
leads to augmentation of the phenotypic expression  of the product controlled 
by one and to partial suppression of the product determined by the other. 
Knowledge of the biochemical basis of binary capsulation can be used to 
indicate the presence of uronic acid in the capsular polysaccharide of a pneumo- 
coccal type the composition of the capsule of which is unknown. 
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